{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:40:38Z","timestamp":1768588838104,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jneuroim.2020.577314","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T20:52:38Z","timestamp":1594155158000},"page":"577314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis"],"prefix":"10.1016","volume":"346","author":[{"given":"Gunnar","family":"Houen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Heiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole H.","family":"Trier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette H.","family":"Draborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Benros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u016bta","family":"Zinkevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Petraityt\u0117-Burneikien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaldas","family":"Ciplys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimantas","family":"Slibinskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette L.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577314_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","article-title":"Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis","volume":"91","author":"Abrahamyan","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","article-title":"Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis","volume":"70","author":"De Jager","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jneuroim.2016.10.001","article-title":"MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative multiple sclerosis patients","volume":"300","author":"Dias-Carneiro","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1352458512451942","article-title":"Epstein-Barr virus, latitude and multiple sclerosis","volume":"19","author":"Disanto","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0040","first-page":"869","article-title":"MMR immunisation. Health professionals should strongly recommend this immunisation","volume":"323","author":"Elliman","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0055","first-page":"277","article-title":"Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum","volume":"109","author":"Franciotta","year":"2009","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/135245859800400106","article-title":"Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI","volume":"4","author":"Frederiksen","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0065","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0070","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0075","article-title":"Measles after MMR-vaccination","volume":"161","author":"van Grootveld","year":"2017","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/bmj.323.7303.32","article-title":"10-minute consultation: MMR immunisation","volume":"323","author":"Harnden","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-016-0049-7","article-title":"The MRZ reaction in primary progressive multiple sclerosis","volume":"14","author":"Hottenrott","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0090","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00415-018-8779-x","article-title":"The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis","volume":"265","author":"Hottenrott","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jns.2008.08.002","article-title":"The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity?","volume":"280","author":"Jarius","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","article-title":"The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature","volume":"264","author":"Jarius","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","article-title":"Virus infections in the nervous system","volume":"13","author":"Koyuncu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-015-1511-3","article-title":"Neurotropic virus infections as the cause of immediate and delayed neuropathology","volume":"131","author":"Ludlow","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review","volume":"264","author":"Mailand","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0125","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ane.12775","article-title":"Viruses and endogenous retroviruses in multiple sclerosis: from correlation to causation","volume":"136","author":"Mentis","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0130","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1007\/s12035-017-0530-6","article-title":"Viruses and multiple sclerosis: from mechanisms and pathways to translational research opportunities","volume":"54","author":"Mentis","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0135","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.3395","article-title":"Class II HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","author":"Moutsianas","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000341902","article-title":"Modelling genetic susceptibility to multiple sclerosis with family data","volume":"40","author":"O'Gorman","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0150","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","author":"Optic Neuritis Study","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0155","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.0b013e318215286d","article-title":"Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis","volume":"76","author":"Otto","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mehy.2016.04.025","article-title":"Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: a hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis","volume":"91","author":"Otto","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0165","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1177\/1352458513506505","article-title":"Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: yes","volume":"19","author":"Pakpoor","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1586\/ern.13.6","article-title":"Epstein-Barr virus and multiple sclerosis: association or causation?","volume":"13","author":"Pakpoor","year":"2013","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00415-009-5296-y","article-title":"Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis","volume":"257","author":"Pohl","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clineuro.2008.12.004","article-title":"A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting","volume":"111","author":"Regeniter","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0185","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","article-title":"Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain","volume":"37","author":"Reiber","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00415-017-8656-z","article-title":"Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature","volume":"265","author":"Ruprecht","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0195","first-page":"375","article-title":"Detection of oligoclonal bands in patients with neurologic diseases: comparison between agarose gel-, immunofixation- and isoelectric-focusing electrophoresis","volume":"61","author":"Shan","year":"1998","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0200","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.conb.2007.08.003","article-title":"Wrapping it up: the cell biology of myelination","volume":"17","author":"Simons","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jneuroim.2020.577314_bb0205","series-title":"The Dansh Childhood Vaccination Programe","author":"Sundhedsstyrelsen","year":"2015"},{"key":"10.1016\/j.jneuroim.2020.577314_bb0210","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820302484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820302484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:37:59Z","timestamp":1759048679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820302484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"alternative-id":["S0165572820302484"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577314","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577314"}}